Surface immunoglobulin-negative acute lymphoblastic leukaemia with predominant L1 morphology, occasional L3 cells and t(8;22).
Reid
Michael M
MM
Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Drewery
Colin
C
Windebank
Kevin P
KP
D018941:Antigens, CD19 / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002675:Child, Preschool; D002892:Chromosomes, Human, Pair 22; D002898:Chromosomes, Human, Pair 8; D020732:Cytogenetic Analysis; D004253:DNA Nucleotidylexotransferase / Q000032:analysis; D003937:Diagnosis, Differential; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D008214:Lymphocytes / Q000276:immunology*; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D008297:Male; D015260:Neprilysin / Q000032:analysis; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000276:immunology*; D014178:Translocation, Genetic
D018941:Antigens, CD19; D006684:HLA-DR Antigens; D007136:Immunoglobulins; D004253:DNA Nucleotidylexotransferase; D015260:Neprilysin